Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NUTM2B-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
DDX25 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NTRK3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GABBR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM26F - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM21EP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIGQ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MCTP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AVPR1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSD17B12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC643549 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
ZNF501 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00957 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HAL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on